Gengxi Cai

机构：First People's Hospital of Foshan · ORCID：0000-0003-0575-4314

发表论文 33 篇 · 总被引 366 次 · h-index 12

代表论文

HSP90β Impedes STUB1‐Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma (2023 · Advanced Science · 被引 44)
Plasma-Derived Extracellular Vesicles Circular RNAs Serve as Biomarkers for Breast Cancer Diagnosis (2021 · Frontiers in Oncology · 被引 32)
A radiogenomic multimodal and whole-transcriptome sequencing for preoperative prediction of axillary lymph node metastasis and drug therapeutic response in breast cancer: a retrospective, machine learning and international multicohort study (2024 · International Journal of Surgery · 被引 29)
SNS-023 sensitizes hepatocellular carcinoma to sorafenib by inducing degradation of cancer drivers SIX1 and RPS16 (2022 · Acta Pharmacologica Sinica · 被引 26)
Patient-derived organoids: a promising tool for breast cancer research (2024 · Frontiers in Oncology · 被引 22)
ARV-771 Acts as an Inducer of Cell Cycle Arrest and Apoptosis to Suppress Hepatocellular Carcinoma Progression (2022 · Frontiers in Pharmacology · 被引 19)